Skip to content
Forest Global Training Partners
Home Services AI Governance AI Risk Encyclopedia Contact Us
AI Risk Encyclopedia AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. Vivodyne to Replace Animal Testing With $40 Million…

AI Risks May 29, 2025 · businesswire.com

Vivodyne to Replace Animal Testing With $40 Million Funding to Reverse 95% Clinical Trial ...

... failures . Vivodyne's AI generates clinically predictive human datasets, already in use by most of the world's top pharmaceutical firms. Series A ...

Read the original at businesswire.com ↗

Topics
HealthcareMarkets & Investment
Tracked via
“AI Falures”

Related articles

  • Gladly: Customer Service Innovation Leader Secures $40 Million AI Risks · Sep 28, 2024
  • Clinical trial statistics gets an AI -era overhaul AI Risks · Jun 15, 2026
  • Best Practices for Reducing Risk Upfront in a Clinical Trial AI Risks · Feb 22, 2025
  • FDA Moves On Two Fronts: AI Compliance Enforcement And Clinical Trial Innovation AI Risks · Jun 04, 2026
  • NetraMark at HC Wainwright: AI pitch targets drug trial failures - Investing.com AI Risks · Sep 11, 2026
  • How is AI Supporting Clinical Trial Design? | PharmExec AI Use Cases · Jan 08, 2026

AI Risk Encyclopedia is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact